p27KIP1 is a tumor suppressor gene in mice and a negative prognostic indicator in human cancers. Since the p27 gene is rarely mutated, there is the unique possibility to restore the function of a tumor suppressor by inhibiting negative regulation. We developed a functional genomics assay to discover regulators of p27. Inhibitor of DNA binding 3 (Id3) and galactokinase (Glk1) were isolated. The identification of ld3, a known cell cycle regulator whose expression inversely correlates with p27, validates our approach. Glk1 is a novel regulator of p27, and preliminary results indicate that Glk1 phosphorylates p27. The objectives of this proposal are to ascertain the mechanisms used by Id3 and Glk1 to decrease p27 protein. Since Id3 represses gene expression, Id3 inhibition of p27 transcription will be tested. For Glk1, the phosphorylation site in p27 will be identified, and the biological significance of this event determined. Additionally, tumor studies in mice carrying mutations for the Glk1 target site and mice overexpressing Glk1 will be conducted. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA094655-03
Application #
6899868
Study Section
Special Emphasis Panel (ZRG1-F09 (20))
Program Officer
Lohrey, Nancy
Project Start
2003-06-01
Project End
2006-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
3
Fiscal Year
2005
Total Cost
$53,492
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Garrett-Engele, Carrie M; Tasch, Michael A; Hwang, Harry C et al. (2007) A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet 3:e219